Price
$211.94+1.67%Social Signal Score
Analyst Ratings
35 analystsRevenue
$1.46B+214.46%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Michael J. Farrell
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 11,370
- Beta
- 0.77
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 10.96
Financials
Revenue
$1.46B+214.5%Net Income
$383.43M+403.8%EBITDA
$492.96M+300.2%Free Cash Flow
$1.65B+2283.3%EPS (diluted)
$2.64+388.9%Shares Outstanding (diluted)
144.98M+2.0%Operating Expenses
$105.73MCash & Debt
$1.47BReturn of Capital
$1.05BRevenue by Segment (annual)
$4.69BDividend per Share
$0.66Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $5.65B | $1.52B | $10.44 |
| 2025 | $5.15B | $1.40B | $9.55 |
| 2024 | $4.69B | $1.02B | $6.94 |
| 2023 | $4.22B | $897.56M | $6.12 |
| 2022 | $3.58B | $779.44M | $5.34 |
| 2021 | $3.20B | $474.50M | $3.27 |
| 2020 | $2.96B | $621.67M | $4.31 |
| 2019 | $2.61B | $404.59M | $2.83 |
| 2018 | $2.34B | $315.59M | $2.21 |
| 2017 | $2.07B | $342.28M | $2.42 |
| 2016 | $1.84B | $352.41M | $2.51 |
| 2015 | $1.68B | $352.89M | $2.51 |
| 2014 | $1.55B | $345.27M | $2.44 |
| 2013 | $1.51B | $307.13M | $2.15 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from RMD's reported EPS growth of 12.9% a year over 13 years.
- EPS in 5 years
- $19.31
- Implied price
- $366.88
- Return from $218.89
- 10.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $182.40 — -16.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 13 | 16 | 19 | 22 | 25 |
|---|---|---|---|---|---|
| 2.9% | -6.3% | -2.4% | 1.1% | 4.1% | 6.8% |
| 7.9% | -1.8% | 2.4% | 6.0% | 9.1% | 11.9% |
| 12.9% | 2.8% | 7.1% | 10.9% | 14.2% | 17.1% |
| 17.9% | 7.3% | 11.9% | 15.8% | 19.2% | 22.3% |
| 22.9% | 11.9% | 16.6% | 20.7% | 24.3% | 27.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
86+72.13%Social Signal Score
Mentions (45)
- News (Marketaux)raskmedia.com.au·2d ago·Positive
RMD share price: why investors like healthcare shares Founded in 1989 by Peter Farrell in Aust[+234 characters]
View source ↗ - News (Marketaux)raskmedia.com.au·9d ago·Positive
QAN shares: your next growth investment? RMD shares ResMed is a medical[+314 characters]
View source ↗ - Newsmarketbeat.com·14d ago·Neutral
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand ResMed NYSE: RMD outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing demand generation, patient adherence and ongoing product innovation in sleep and respiratory care.
View source ↗ - News (RSS)yahoo·16d ago·Neutral
A $2.25 Million Portfolio, Two Withdrawal Plans: One Triggers IRMAA and RMD Taxes, One Never Does
View source ↗ - News247wallst.com·16d ago·Negative
She Retired at 60 With $410,000 in a 403(b) and Lived on Her Pension for 13 Years. By 73 It Was $770,000, and Her First RMD Was $29,000, on Top of the Pension She left her 403(b) untouched for 13 years while her pension covered every bill, which looked like patience but turned out to be a costly mistake that played out in tax brackets, Medicare premiums, and Social Security she never expected to lose.
View source ↗ - News (RSS)yahoo·17d ago·Neutral
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
View source ↗ - News (Marketaux)insidermonkey.com·17d ago·Positive
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures ResMed Inc. (NYSE:[+283 characters]
View source ↗ - News (RSS)fool·17d ago·Negative
Your RMD Deadline Is Closer Than You Think -- Miss It and Pay Dearly With roughly 15 weeks until New Year's Eve, it's time to begin thinking about your next required minimum distribution.
View source ↗ - News (RSS)yahoo·18d ago·Neutral
A 401(k) Millionaire’s First RMD Is About $37,700. Add a $40,000 Social Security Benefit and 85% of the Benefit Turns Taxable the Same Year
View source ↗ - News (RSS)investing·20d ago·Positive
Why is ResMed stock rallying today?
View source ↗ - News (RSS)investing·20d ago·Positive
ResMed stock jumps 3% on RBC Capital upgrade to Outperform
View source ↗ - News (RSS)seekingalpha·20d ago·Positive
ResMed Inc. (RMD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsbarrons.com·20d ago·Positive
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like. Setbacks for competitors have positioned ResMed to capture more market share.
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Wall Street Lunch: AI Regulation Hopes Fade After Trump Calls AI Concerns A 'Hoax' AI regulation odds have sharply declined after Trump dismissed AI takeover concerns during a public call with Nvidia (NVDA) CEO Jensen Huang. ResMed (RMD) was upgraded to Outperform by RBC Capital Markets, with a price target raised to $262, citing strong Q4 results and expected high-single-digit EPS growth.
View source ↗ - Newsseekingalpha.com·20d ago·Positive
ResMed Inc. (RMD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ResMed Inc. (RMD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - News247wallst.com·21d ago·Neutral
Roth Conversions From 63 to 67: Why a Couple’s $500,000 Window Slams Shut at the First RMD Most couples retiring at 63 with a million-dollar traditional IRA assume they have a full decade before forced withdrawals shrink their options, but three separate tax triggers conspire to close that window years earlier than anyone expects.
View source ↗ - News (RSS)yahoo·21d ago·Negative
ResMed Stock: Is RMD Underperforming the Healthcare Sector?
View source ↗ - News (RSS)yahoo·22d ago·Neutral
A 72-Year-Old Can Still Move Up to $210,000 Into a QLAC and Cut Next Year’s RMD by About $7,900. The Check Doesn’t Start Until 85, and Neither Does the Tax
View source ↗ - News (RSS)yahoo·24d ago·Neutral
Why Retirees With $1.4 Million Are Taking $60,000 a Year at 62 Instead of Waiting for a $100,000 RMD at 73
View source ↗ - News (RSS)seekingalpha·25d ago·Neutral
ResMed: A Significant Upside Despite The Perceived Risk
View source ↗ - Newsseekingalpha.com·26d ago·Neutral
ResMed: A Significant Upside Despite The Perceived Risk ResMed has de-rated from 30x to under 21x earnings despite 17% EPS growth, driven by narrative rather than fundamentals. Recurring mask and consumables revenue, now 42% of the sleep and breathing segment, is underappreciated and grew 13% last year. Two major risks—sleep apnea pill and reimbursement—are less material for RMD than feared; Philips' US return poses the most credible threat.
View source ↗ - News247wallst.com·26d ago·Neutral
A $2.6 Million 401(k) at 74 Produces a $102,000 RMD That Lands a Retiree in the 24% Bracket A seven-figure 401(k) sounds like a retirement victory until the IRS forces a six-figure withdrawal that collides with Social Security, Medicare surcharges, and a bracket wall that swallows nearly 40 cents of every top dollar.
View source ↗ - News (RSS)yahoo·26d ago·Negative
He Retired at 63 With $520,000 in a 401(k) and Lived on Savings for Ten Years. By 73 It Was $850,000, and His First RMD Was $32,000, Every Dollar Taxable
View source ↗ - News (RSS)yahoo·27d ago·Neutral
The IRS Lets You Send Your RMD Straight to Charity and Skip the Tax Entirely. These 3 ETFs Replace the Income You Gave Away
View source ↗ - News247wallst.com·27d ago·Neutral
The IRS Lets You Send Your RMD Straight to Charity and Skip the Tax Entirely. These 3 ETFs Replace the Income You Gave Away A Qualified Charitable Distribution can wipe your RMD off your tax return entirely, but it also kills the income you were counting on. Three ETFs can rebuild that cash flow, and they each do it a completely different way.
View source ↗ - News (RSS)yahoo·27d ago·Positive
$1.5 million in your 401(k)? Here’s what your RMD taxes will look like — and the very best trick to lower them
View source ↗ - News (RSS)yahoo·29d ago·Neutral
A $2.1 Million Portfolio, Two Withdrawal Plans: One Triggers IRMAA and RMD Taxes, One Never Does
View source ↗ - News (RSS)fool·31d ago·Negative
Turning 73? The RMD Deadline You Can't Afford to Miss. It's a blunder that could cost you big time.
View source ↗ - News (RSS)thestreet·33d ago·Neutral
Schwab's tax expert flags a quiet RMD risk for retirees The retirement paycheck the IRS decides for you at 73
View source ↗ - News (RSS)investing·34d ago·Neutral
Frazier Healthcare completes acquisition of MatrixCare from ResMed
View source ↗ - News247wallst.com·37d ago·Negative
She Retired at 64 With $380,000 in a 401(k) and No Income for Nine Years. She Never Converted a Dollar. Her First RMD Was Taxed at 22%. Nine gap years between her last paycheck and her first required withdrawal gave her a legal window to move money at the lowest tax rates she would ever see. She left every one of those years untouched, and the bill that arrived at 73 reflected exactly that choice.
View source ↗ - News247wallst.com·38d ago·Negative
She Bought an Annuity Inside Her IRA at 72. The Check Was Guaranteed. The RMD on It Wasn’t Covered, and the IRS Fined Her 25%. Her annuity check arrived every month like clockwork, so she assumed the IRS was satisfied. It turned out the tax code had a completely separate opinion about the rest of her IRA, and the bill arrived with a five-figure penalty attached.
View source ↗ - News247wallst.com·40d ago·Negative
A $2.3 Million 401(k) at 76 Produces a $97,000 RMD That Pushes a Couple Out of the 22% Bracket for Good A couple in their mid-seventies with a well-funded IRA suddenly faces a mandatory withdrawal they cannot refuse, and the ripple effects reach well beyond their tax bracket into Medicare premiums they never saw coming.
View source ↗ - News (RSS)yahoo·41d ago·Neutral
ResMed Stock: Analyst Estimates & Ratings
View source ↗ - News (Marketaux)raskmedia.com.au·44d ago·Positive
RMD share price: why investors like healthcare shares Founded in 1989 by Peter Farrell in Aust[+234 characters]
View source ↗ - News (RSS)fool·44d ago·Negative
3 of the Worst RMD Mistakes Retirees Make -- and How to Avoid Them Steer clear of these to avoid financial pain.
View source ↗ - News247wallst.com·46d ago·Neutral
The IRS Makes You Sell Whether the Market Is Up or Down. These 3 ETFs Fund the RMD Without Touching a Share Turning 73 changes the math on your retirement account. The IRS no longer lets your traditional IRA compound in peace.
View source ↗ - News (RSS)venturebeat·47d ago·Positive
…processing more than 10 billion requests per month through its AI Gateway. Customers and deployments cited by TrueFoundry have included NetApp, Siemens Healthineers, ResMed, Automation Anywhere, Nvidia, Games24x7 and others; Gutgutia also named NetApp, Siemens, Synopsys and Automation Anywhere among Fortune 1000 organizations working with the company in his interview with VentureBeat. TrueFoundry has also been expanding through acquisition. In June 2026 it acquired UK-based Seldon AI, a longtime…
View source ↗ - News (Marketaux)raskmedia.com.au·48d ago·Positive
QAN shares: your next growth investment? RMD shares ResMed is a medical[+314 characters]
View source ↗ - News (RSS)yahoo·49d ago·Neutral
ResMed’s (RMD) Sleep Business Booms Even As One Product Stumbles
View source ↗ - Newsglobenewswire.com·49d ago·Neutral
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced that Carol Burt will become Lead Director on November 15, 2026. She will succeed Ron Taylor, Resmed's current Lead Director, who is not standing for reelection at the company's 2026 Annual Meeting of Stock…
View source ↗ - News (RSS)fool·51d ago·Neutral
3 Little-Known RMD Rules That Could Save You Money You may have more options than you thought.
View source ↗ - Newsfool.com·51d ago·Neutral
3 Little-Known RMD Rules That Could Save You Money You may have more options than you thought.
View source ↗ - News (Marketaux)raskmedia.com.au·55d ago·Positive
I’m keeping an eye on RMD shares in 2026 ResMed is a medical equipment c[+302 characters]
View source ↗ - Newsmarketbeat.com·58d ago·Neutral
ResMed Q4 Earnings Call Highlights ResMed NYSE: RMD reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share rose 16% to $2.95, while the company expanded gross margin despite continued inflation in electronic components and freight.
View source ↗
Earnings
Thu, Oct 29(in 3 weeks)
Consensus estimate $2.68 per share
Typical surprise +2.1% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$2.95 vs $2.89beat
- Thu, Apr 30$2.86 vs $2.80beat
- Thu, Jan 29$2.81 vs $2.74beat
- Thu, Oct 30$2.55 vs $2.51beat
- Thu, Jul 31$2.55 vs $2.46beat
- Wed, Apr 23$2.37 vs $2.38miss
Estimates and results for RMD via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by RMD officers and directors.
- Bought
- —
- Sold
- $24.2m
0 trades
32 trades
- Farrell Michael J.sold
- Farrell Peter Csold
- Farrell Michael J.sold
- Farrell Peter Csold
- Farrell Michael J.sold
- Farrell Michael J.sold
- Farrell Michael J.sold
- Farrell Michael J.sold
68 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (41d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed May 13, 2026 (30d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Kelly Morrisonhouse · MN03 · disclosed Jun 18, 2025 (14d later)Sell$1,001 - $15,000
- Kelly Morrisonhouse · MN03 · disclosed May 13, 2025 (15d later)Sell$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Feb 14, 2025 (32d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2024 (21d later)Buy$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Jun 14, 2024 (42d later)Sell$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Nov 16, 2023 (30d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (29d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (37d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (8d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (8d later)Sell$1,001 - $15,000
- Thomas Richard Carpersenate · DE · disclosed Sep 5, 2023 (7d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 11, 2023 (15d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 11, 2023 (12d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 12, 2023 (20d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 12, 2023 (24d later)Sell$1,001 - $15,000
- Thomas Richard Carpersenate · DE · disclosed Feb 2, 2023 (22d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.